HealthEquity Reports Second Quarter Ended July 31, 2017 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Nasdaq futures drop over 2% on concerns over AI buildout costs, Fed rate outlook
- Nasdaq 100 set to shed over $1 trillion as tech selloff deepens; SpaceX slides
- Oil prices fall as investors focus on Hormuz flows after peace talks
- SpaceX slides, tech stocks dip — what’s moving markets
- Deutsche Bank cuts gold outlook as Fed repricing weighs on prices
- Spain's ex-transport minister sentenced to 24 years for corruption
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Oppenheimer Remains Bullish on HealthEquity (HQY) Following Solid 2Q
September 6, 2017 9:44 AM EDTOppenheimer reiterated an Outperform rating and $61.00 price target on HealthEquity, Inc (NASDAQ: HQY) following the company's 2Q earnings report. Revenues of $56.9M beat estimates of $55.8M and adjusted EPS of $0.27 beat estimates of $0.18, mainly on tax benefits.
HQY raised its FY18... More
HealthEquity (HQY) Tops Q2 EPS by 12c, Sales Rise 29%; Raises Outlook
September 5, 2017 4:09 PM EDTHealthEquity (NASDAQ: HQY) reported Q2 EPS of $0.27, $0.12 better than the analyst estimate of $0.15. Revenue for the quarter came in at $56.9 million versus the consensus estimate of $55.66 million.
Revenue of $56.9 million, an increase of 29% compared to Q2 FY17.Net income of $16.9 million, an increase of 106% compared to Q2 FY17.Net income per diluted share of $0.27 compared to $0.14 in Q2 FY17.Adjusted EBITDA of $23.9 million, an increase of 30% compared to Q2... More